Trailing-twelve-month (TTM) revenue is $2.25 Billion with a year-over-year growth of (4.59%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $561,741,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $594,803,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-11 |
| Q1 FY2026Period ended 2026-03-31 | $542,127,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $547,495,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $2,246,166,000 |
Current P/S: $358,628,282 market capitalization ÷ $2,246,166,000 TTM revenue = 0.16x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:15:16.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $547.50M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:15:39.443Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Advertising | $876M | $951M | $872M | $716M | $677M | $581M |
| Entertainment | $1.9B | $2.1B | $2.2B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Europe | $386M | $433M | $354M | $329M | $353M | $322M |
| North America | $2.3B | $2.5B | N/A | N/A |
$2.25B
$2.25 Billion
(4.59%)
vs. $2.35B a year ago (TTM)
(4.97%)
5 Year compound annual growth rate
1 Year
(4.59%)
3 Year
(9.62%)
5 Year
(4.97%)
10 Year
(1.83%)
15 Year
+4.66%
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.31B | ($109.51M) | (4.52%) |
| 2024 | $2.42B | ($290.56M) | (10.71%) |
| 2023 | $2.71B | ($384.67M) | (12.42%) |
| 2022 | $3.10B | +$18.94M | +0.62% |
| 2021 | $3.08B | +$262.65M | +9.33% |
| 2020 |
TTM Growth
(4.59%)
3-Year CAGR
(9.62%)
5-Year CAGR
(4.97%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:15:39.443Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| License | N/A | $558M | $606M | $435M | $273M | $278M |
|---|
| Subscription and Circulation | N/A | $1.6B | $1.6B | $1.6B | $1.5B | $1.5B |
|---|
| N/A |
| N/A |
| Other Geographic Locations | $161M | $183M | $168M | $173M | $151M | $150M |
|---|
| UNITED STATES | N/A | N/A | $2.6B | $2.2B | $1.9B | $1.8B |
|---|
| $2.81B |
| ($245.37M) |
| (8.02%) |
| 2019 | $3.06B | +$88.39M | +2.97% |
| 2018 | $2.97B | +$166.24M | +5.93% |
| 2017 | $2.81B | +$50.04M | +1.82% |
| 2016 | $2.76B | +$174.72M | +6.77% |
